Research / UP / Fundamental state Inspectable configuration
State dimensions Filing 0001819516-24-000027 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
306.03% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 50th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.04% · OPTIONAL · VALID
Operating cash generation 56th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-37.44% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-43.98% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 89th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
10.43% · OPTIONAL · VALID
Gross margin 11th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.gross_margin
-0.59% · CORE · VALID
Operating margin 11th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.operating_margin
-41.90% · CORE · VALID
R&D intensity 89th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
5.62% · OPTIONAL · VALID
SBC intensity 78th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
5.69% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Sep 30, 2021 0/7 normalized Level 3 Mar 31, 2022 0/7 normalized Level 3 Jun 30, 2022 0/7 normalized Level 3 Sep 30, 2022 0/8 normalized Level 3 Sep 30, 2022 0/8 normalized Amended as filed Dec 31, 2022 0/8 normalized Level 3 Mar 31, 2023 0/9 normalized Level 3 Jun 30, 2023 0/9 normalized Level 3 Sep 30, 2023 0/9 normalized Level 3 Dec 31, 2023 6/9 normalized Level 3 Mar 31, 2024 7/9 normalized Level 3 Jun 30, 2024 7/9 normalized Level 3 Sep 30, 2024 8/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 49.10%
Current 306.03%
Delta 256.93% Capex Intensity Increased
Previous 1.61%
Current 2.04%
Delta 0.43% Cash Generation Increased
Previous -53.08%
Current -37.44%
Delta 15.64% Growth Decreased
Previous -20.66%
Current -43.98%
Delta -23.31% Inventory Pressure Increased
Previous 1.63%
Current 10.43%
Delta 8.80% Margin Decreased
Previous 1.66%
Current -0.59%
Delta -2.25% Profitability Decreased
Previous -35.39%
Current -41.90%
Delta -6.51% R And D Intensity Increased
Previous 4.94%
Current 5.62%
Delta 0.69% Sbc Intensity Increased
Previous 2.05%
Current 5.69%
Delta 3.64% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.